Obesity Flashcards
Obesity - E/E
One of the most common d/o in medicine
According to WHO 500 million adults worldwide, 42 million children
Increased healthcare costs
Can be one of the most frustrating d/o to manage
Advances have been made with time
Continues to increase nationwide
Obesity stigma
Women > Men
68% of Americans are overweight based on BMI
Socioeconomic factors play a significant role
Ethnicity can have a major influence
Gentic predisposition
Medical condition
MULTIFACTORIAL!
Genetics and obesity
Five gene identified
All affect control of appetite from a neuroendocrine standpoint
- Leptin
- Grehlin
Economical Impacts of Obesity - Personal Level
$1,000's Additional medication cost Out-of-pocket healthcare expenses Costs related to inactivity Commercial weight loss program fees Additional food costs
Economical Impacts of Obesity - National level
Billions yearly
Economical Impacts of Obesity - Business level
More than $12 billion for employee care
5% of total healthcare expenditures
Assessing obesity
EVERYONE!!
Record and trend BMI
Assess for co-morbid dz in anyone with a BMI of 25 or greater
Obesity related Co-morbidities
DM-2 HTN OSA Dyslipidemia OA GERD Ca Back/joint pain Urinary stress incontinence Asthma OHS CAD / CHD NASH / NAFLD Pseudotumor cerebri Infertility - PCOS Psychological - Depression / Anxiety
BMI of normal weight
18.5 - 24.9
BMI of overweight
25 - 29.9
BMI of Obese (Class I)
30 - 34.9
BMI of Obese (Class II)
35-39.9
BMI of extremely obese (Class III)
40+
BMI
A measurement based on weight and height
Used to help determine the degree or severity of a person’s obesity
Medical evaluation
Age of onset Weight changes FHx Social hx Occupational hx Eating habits Exercise habits Previous effeorts to address Assess for eating d/o - Laxative use - Diuretic use - Nutritional supplements
Secondary Obesity
<1% have an attributable cause Hypothyroidism Cushing's dz or syndrome Other genetic conditions - Prader-Willi Syndrome - Alstrom Syndrome - Cohen Syndrome
Weight loss strategies - in general
Dietary intervention Physical activity Behavior modification Drug tx Weight loss sx in the severely obese
Weight loss strategies - Dietary intervention
About 10% of body weight and be healthfully lost in 6 months
Diets are prone to failure for many reasons
Weight loss strategies - Physical activity
Increased activity can improve general health, but may have little impact on total body weight in morbid obesity
Weight loss strategies - behavior modification
Can contribut to overall weight loss program
Requires ongoing professional contact
Failure rate can be high
Weight loss strategies - Drug tx
Weight is typically regained when tx ends
Weight loss strategies - sx
Weight loss sx in the severely obese
The most effective approach for long-term weight loss
Dietary intervention - in general
Changing dietary habits
Daily Caloric intake
Long term success of dieting alone is poor
The higher the weight loss the harder it is to keep it off
Dietary intervention - Changing Dietary Habits
Diets
Calorie counting
Dietary intervention - Daily caloric intake
Requirements depend on numerous factors - Age - Sex - Physical activity - Health conditions Males: 2000-3000 /day Females: 1600-2400/day
Dietary intervention - Long term success
Only 20% will lose 20 lbs and keep it off for 2 years
Physical Activity
Calorie expenditure > intake
Typically a combination is best
5-7 days/week
Moderate Activity (100-130HR)
What is the best way to optimize fatty weight loss
A combination of diet and exercise
Behavior Modification
Esp. if weight gain is related to psychological eating d/o
Maintenance
Social support system!
Medications - in general
OTC & prescriptions
Routine f/u
Do they work?
Medications - NIH/FDA recommendations
Part of comprehensive program
BMI > 30
BMI > 27 if they have a medical co-morbidity
Medications - Examples
Xenical (Orlistat) Belviq (Lorcaserin) Phentermine Topriamate Saxenda (Liraglutide) Qsymia Contrave
Xenical (Orlistat)
Long term tx TID with meals MOA - GI tract SE - GI Risks - Malabsorption 2-4 kg > placebo
Belviq (Lorcaserin)
Shorter term tx MOA - SSRA Risks - NMS - Serotonin syndrome - Breast tumors? - Valvular HD? 3% > weight loss than placebo
Phentermine
Short term Strict f/u is required Two doses - 15 mg -37.5 mg - QD 1-2h after breakfast SE/risk - Insomnia - Fatigue - CV Better results -7.8% & 9.8% > placebo
Topiramate
Anticonvulsant
Off label use for weight loss
Typical dose - 25mg BID
Black box warning - birth defects
Saxenda (liraglutide)
Injectable Incretin (GLP-1 agonist) FDA approved for weight loss Dosage - 3 mg SE - GI; Pancreatitis Black box warning - carcinogen? 3.7-4.5% > loss than placebo at 1 year
Combination drugs
Qsymia
Contrave
Qsymia
Phentermine / Topirmate Dosage: 7.5/46mg; 15/92 mg Contraindication: Hyperthyroidism; Glaucoma SE - Dizziness - Paresthesias - CV - Psychologial - GI Black box warning - Birth defects 6.7% & 8.9% weight loss at 1 year
Contrave
Bupropion / Naltrexone Dosage - 8/90 mg - Complicated dosing to start medication - EDUCATE! Risk / SE - CV outcome in trial progress (HTN; tachycardia) - GI - Neuropsychiatric 2-4% > Placebo